Treatment Breakthroughs for NSCLC

Are Patients With NSCLC Eligible for Immunotherapy?

Doctor Explains Immunotherapy Eligibility for NSCLC Patients

Are patients with non-small cell lung cancer (NSCLC) eligible for immunotherapy? Wade T. Iams, MD, Assistant Professor of Medicine at the Vanderbilt University Medical Center, explains which lung cancer patients would benefit from immunotherapy and if it should be combined with chemotherapy or immune checkpoint inhibitors.

This article was originally published January 24, 2022 and most recently updated February 1, 2022.
© 2024 HealthCentral LLC. All rights reserved.

Treatment Breakthroughs for NSCLC